CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
Just a reminder that the revised client forms implement today! Don't forget to toss your o...